Endocrine complications in transfusion dependent thalassaemia in Penang hospital

Medical Journal of Malaysia

Volumn 63, Issue 2, 2008, Pages 109-112

  Ong, Choo Khoon ^a,b   Lim, S L ^a   Tan, W C ^a   Ong, E E ^a   Goh, A S ^a  

^a Penang Adventist Hospital   (Malaysia)

^b NONE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; ASIAN; BLOOD TRANSFUSION; CHILD; CHINESE; CLINICAL ARTICLE; COHORT ANALYSIS; DELAYED PUBERTY; DIABETES MELLITUS; EARLY DIAGNOSIS; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; INFANT; IRON CHELATION; IRON OVERLOAD; MALAYSIA; MALE; MENSTRUATION DISORDER; OSTEOPOROSIS; PREVALENCE; PRIMARY AMENORRHEA; RETROSPECTIVE STUDY; SECONDARY AMENORRHEA; SHORT STATURE; THALASSEMIA;

ADULT; BLOOD TRANSFUSION; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; THALASSEMIA;

EID: 55049096463     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kwan EY, Lee AC, Li AM et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. J Paediatr Child Health. 1995; 31(2): 83-7.
2. De Sanctis V. Endocrine disorders: Growth, fertility and diabetes. European Genetic Foundation Website. 2006. http://www.eurogene.org.
3. Shlomit S, Doron C, Naomi W et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol 2005; 74: 93-100.
4. Alireza AS, Bekheimia M R, Kamgar M et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocrine Disorders 2003; 3: 4.
5. H Karamifar, M Shahriari and N Sadjadian. Prevalence of endocrine complications in thalassaemia major in the Islamic Republic of Iran. Eastern Mediterranean Health Journal. 2003; 9(1-2): S5-60.
6. Italian Working Group on Endocrine Complications in Non-Endocrine Disease. Multicenter study on prevalence of endocrine complications in thalassemia major. Clin Endocrinol 1995; 42: 581-86.
7. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. British Journal of Haematology 2004; 127: 127-39.
8. Hamdollah K, Mehdi S, Gholam H A. Failure of puberty and linear growth in beta thalassaemia major. Turk J Haematol 2005; 22(2): 65-69.
9. Jensen CE, Tuck SM, Agnew JE et al. High prevalence of low bone mass in thalassaemia major; British Journal of Haematology 1998; 103: 911-15.
10. Heshmat M, Zohreh O. Prevalence of Growth and Puberty Failure with Respect to Growth Hormone and Gonadotropins Secretion in Beta-Thalassemia Major. Arch Iranian Med 2006; 9 (4): 329-34.
11. Costin G, Kogut M, Hyman CB and Ortega J. Endocrine abnormalities in thalassemia major. Am J Dis Chil 1979; 133: 497-502.
12. Suda K. Hemosiderin deposition in the pancreas. Arch Pathol Lab Med 1985; 109: 996-99.
13. Masala A, Meloni T, Gallisai D et al. Endocrine functioning in multitransfused prepubertal patients with homozygous beta thalassaemia. J Clin Endocrinol Metab 1984; 58: 667-70.
14. Zervas A, Katopodi A, Protonotariou A et al. Assessment of thyroid function in two hundred patients with beta-thalassaemia major. Thyroid 2002; 12: 151-4.
15. Weintrob NB, Olivieri N F, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effect of age at the start of iron chelation therapy on gonadal function in beta thalassemia major. N Eng J Med 1990; 323: 713-19.